These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5131655)

  • 21. [Clinical experiences with the amphocholereticum Oddibil].
    Zawodsky L
    Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F; Spada S
    Clin Ter; 1969 Aug; 50(3):203-32. PubMed ID: 5387397
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic properties of the cholagogue preparation flastapiol in biliary tract diseases in children].
    Shmorgun SS; Zinchenko TV; Maksiutina NP
    Pediatr Akus Ginekol; 1974; (2):22-4. PubMed ID: 4438009
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the choleretic value of ragacholyl in man].
    Rev Med Chir Mal Foie; 1971; 46(1):45-52. PubMed ID: 5580580
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical study of xylite as a cholagogue].
    Vaĭnshteĭn SG; Maksudova DKh; Pivikova MI
    Klin Med (Mosk); 1970 Jan; 48(1):126-8. PubMed ID: 5419551
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cholagogue and choleretic action of mineral waters].
    Messina B
    Clin Ter; 1974; 70(2):110-2. PubMed ID: 4408868
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of chronic inflammatory diseases of the biliary tracts in children using the new cholagogue preparation "Stachyren"].
    Shmorgun SS; Zinchenko TV; Kuz'menko IA
    Farm Zh; 1971; 26(6):48-50. PubMed ID: 5163057
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experimentation with Régacholyl].
    Rev Med Chir Mal Foie; 1970; 45(6):333-4. PubMed ID: 5502127
    [No Abstract]   [Full Text] [Related]  

  • 29. [Alpha-(1-hydroxy-4-phenylcyclohexyl)-butyric acid, a synthetic choleretic. Pharmacology, clinical aspects and review considerations on the experience of a few years of systematic use of the choleretic alone or in combination with other substances in hepatocholecystic syndromes].
    Barbi G
    Minerva Gastroenterol; 1966; 12(2):64-7. PubMed ID: 5960468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"].
    Gheorghescu B; Steflea D; Jovin G; Suseanu I
    Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of biliary tract diseases with Felwiten].
    Gonciarz Z
    Pol Tyg Lek; 1971 Jul; 26(28):1084-6. PubMed ID: 5096682
    [No Abstract]   [Full Text] [Related]  

  • 32. [Choleretics of synthetic and plant origin].
    Skakun MP
    Farm Zh; 1968; 23(3):18-23. PubMed ID: 4236350
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical study of a synthetic choleretic: alpha-(1-hydroxy-4-phonyl-cyclohexyl)-butyric acid (MG 4833)].
    Montemartini C; Fontana S; Calderoni AG
    Clin Ter; 1967 Jul; 42(2):121-39. PubMed ID: 5598371
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cholelithin therapy of angiocholecystites and dyskinesias of bile ducts in children].
    Shmorgun SS; Cherniavskaia VG
    Pediatr Akus Ginekol; 1967; 2():27-9. PubMed ID: 5610524
    [No Abstract]   [Full Text] [Related]  

  • 35. [Piprozoline in clinical trials (author's transl)].
    Schleicher E
    Arzneimittelforschung; 1977; 27(2b):520-6. PubMed ID: 326261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Personal experiences in the treatment of bile duct diseases using Genebil].
    De Marcos Perez VM
    Rev Esp Enferm Apar Dig; 1969 Nov; 29(4):569-84. PubMed ID: 5363141
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of a new synthetic cholerectic agent in the therapy of some gastro-duodeno-biliary and pancreatic diseases].
    Azzena D
    Clin Ter; 1972 Apr; 61(1):47-58. PubMed ID: 5039601
    [No Abstract]   [Full Text] [Related]  

  • 38. [Choleretics].
    Tagliareni F
    Minerva Nipiol; 1967; 17(4):136-41. PubMed ID: 5620855
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experiences with a new spasmo-choleretic].
    Meissner O; Quitzow G
    Wien Med Wochenschr; 1966 Oct; 116(40):816-8. PubMed ID: 5925778
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.